ATP disodium

Catalog No.S1985 Synonyms: Adenosine-Triphosphate disodium, ATP disodium salt, Adenosine 5'-triphosphate

For research use only.

ATP Disodium (Adenosine-Triphosphate disodium, ATP disodium salt, Adenosine 5'-triphosphate) is a disodium salt form of adenosine-triphosphate which is a multifunctional nucleoside triphosphate.

ATP disodium Chemical Structure

CAS No. 987-65-5

Selleck's ATP disodium has been cited by 15 publications

Purity & Quality Control

Related Other Products

Biological Activity

Description ATP Disodium (Adenosine-Triphosphate disodium, ATP disodium salt, Adenosine 5'-triphosphate) is a disodium salt form of adenosine-triphosphate which is a multifunctional nucleoside triphosphate.
In vitro

ATP release and autocrine feedback through P2Y2 and A3 receptors provide signal amplification, controlling gradient sensing and migration of neutrophils. [1] ATP results in production of reactive oxygen species (ROS), which stimulates the phosphatidylinositol 3-kinase (PI3K) pathway and subsequent Akt and ERK1/2 activation. ATP-dependent ROS production and PI3K activation also stimulate transcription of genes required for an oxidative stress response. ATP-mediated ROS-dependent PI3K is required for activation of caspase-1 and secretion of IL-1beta and IL-18. [2] ATP potently stimulates TNF-alpha release, resulting from TNF-alpha mRNA expression in rat cultured brain microglia. ATP-induced TNF-alpha release is Ca(2+)-dependent, and a sustained Ca(2+) influx correlated with the TNF-alpha release in ATP-stimulated microglia. ATP-induced TNF-alpha release is inhibited by PD 098059, an inhibitor of extracellular signal-regulated protein kinase (ERK) kinase 1 (MEK1), which activates ERK, and also by SB 203580, an inhibitor of p38 mitogen-activated protein kinase. ATP rapidly activates both ERK and p38 even in the absence of extracellular Ca(2+). [3] ATP-induced cytotoxicity is mediated by classical alterations of apoptosis, including membrane blebbing, nuclear condensation, and DNA fragmentation. ATP but not other nucleotides lead to the potent and selective activation of NF-κB in microglial cells through a P2Z receptor-mediated pathway. [4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
1321N1 Mk\wSpVv[3Srb36gZZN{[Xl? M37McWFod26rc4SgZYN1cX[rdImgZZQhVi22ZYLtbY5idCCKQTDldIl1d3CnLYTh[4dm\CCqdX3hckBROll{IILlZ4VxfG:{IGmxNVRCKG23dHHueEBmgHC{ZYPz[YQhcW5iaIXtZY4hOTN{MV6xJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGmwdILhZ4VtdHWuYYKgZ4Ft[2m3bTDs[ZZmdCxiRVO1NF0xNjB|MEJOwG0v NVz3[|NmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm0NVkzODRpPkG5OFE6OjB2PD;hQi=>
1321N1 NUfwXFBXTnWwY4Tpc44h[XO|YYm= MVjB[49vcXO2IHHjeIl3cXS7IHH0JG4ufGW{bXnuZYwhUEFiZYDpeI9x\S22YXfn[YQhf2muZDD0fZBmKDRiaIXtZY4hWDK\MjDy[YNmeHSxcjDlfJBz\XO|ZXSgbY4hcHWvYX6gNVMzOU5zIHPlcIx{KGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJIlvfHKjY3XscJVt[XJiY3HsZ4l2dSCuZY\lcEwhTUN3ME2wMlA3OzIQvF2u MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTRzOUKwOEc,OTl2MUmyNFQ9N2F-
1321N1 M3m4PWZ2dmO2aX;uJIF{e2G7 M4TJ[mFod26rc4SgZYN1cX[rdImgZpkhdWWjc4XybY5oKGmwb4PpeI9tKHCqb4PwbIF1\SCjY3P1cZVt[XSrb36gbY4hOTN{MV6xJIh2dWGwIHHzeJJw[3m2b33hJINmdGy|IIP0ZYJtgSCneIDy[ZN{cW6pIHj1cYFvKFB{WTDweZJqdm:lZYD0c5IhOixiRVO1NF0xNjB6Nd88UU4> Mn\VQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTF7OEW0O|YoRjFzOUi1OFc3RC:jPh?=
1321N1 NIj1SYxHfW6ldHnvckBie3OjeR?= NIS4N|dC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHAzYTJicnXj[ZB1d3JiZYjwdoV{e2WmIHnuJIh2dWGwIEGzNlFPOSClZXzsd{Bkd2W6cILld5NqdmdicHjvd5Bpd2yrcHHz[UBENWGldHn2ZZRqdmdiRzDwdo91\WmwIHHzd4V{e2WmIHHzJIlvd3OrdH;sJJBpd3OyaHH0[UBxem:mdXP0bY9vKGK7IIPjbY51cWyuYYTpc44heHKxeHntbZR6KGG|c3H5MEBGSzVyPUCuNFg2|ryPLh?= MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTRzOUi2PEc,OTl2MUm4Olg9N2F-
1321N1 NFSxcYdHfW6ldHnvckBie3OjeR?= M{L4O2Fod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gdoVkd22kaX7hcpQhWDK\MjDy[YNmeHSxcjDlfJBz\XO|ZXSgbY4hOTN{MV6xJINmdGy|IHHzd4V{e2WmIHHzJJN1cW23bHH0bY9vKG:oIIDoc5NxcG:uaYDhd4UhSyxiRVO1NF0xNjB6Nd88UU4> NFP6fIk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{OwNlM6QCd-MUezNFI{QTh:L3G+
1321N1 NIq4foJHfW6ldHnvckBie3OjeR?= NHrBXFdC\2:waYP0JIFkfGm4aYT5JIF1KE5vdHXycYlv[WxiSFGg[ZBqfG:yZT30ZYdo\WRid3ns[EB1gXCnIEOgbJVu[W5iUELZNkBz\WOncITvdkBmgHC{ZYPz[YQhcW5iaIXtZY4hOTN{MV6xJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGmwdILhZ4VtdHWuYYKgZ4Ft[2m3bTDs[ZZmdCxiRVO1NF0xNjB7NUlOwG0v M1nYOVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NEG5NlA1Lz5zOUSxPVIxPDxxYU6=
1321N1 NFLXT3NHfW6ldHnvckBie3OjeR?= NVHFWpRISWexbnnzeEBi[3Srdnn0fUBifCCQLYTldo1qdmGuIFjBJIVxcXSxcHWteIFo\2WmIHj1cYFvKFB{WUKgdoVk\XC2b4KgVlE6PEhibYX0ZY51KGW6cILld5Nm\CCrbjDoeY1idiBzM{KxUlEh[2WubIOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iaX70doFk\WyudXzhdkBk[WylaYXtJIxmfmWuLDDFR|UxRTBwMUGx{txONg>? NFLhXoI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUSxPVIxPCd-MUm0NVkzODR:L3G+
1321N1 NUHNbY1iTnWwY4Tpc44h[XO|YYm= MoDqRYdwdmm|dDDhZ5Rqfmm2eTDheEBPNXSncn3pcoFtKEiDIHXwbZRweGVvdHHn[4VlKGi3bXHuJHAzYTJicnXj[ZB1d3JiWUG5PGEhdXW2YX70JIV5eHKnc4Pl[EBqdiCqdX3hckAyOzJzTkGgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hcW62cnHj[YxtfWyjcjDjZYxkcXWvIHzleoVtNCCHQ{WwQVAvOTMQvF2u MknjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl2MUmyNFQoRjF7NEG5NlA1RC:jPh?=
MDCK NVXXeZYyTnWwY4Tpc44h[XO|YYm= NIDFNm0yOCC3TR?= MWnJcoR2[3Srb36gc4YhcW62cnHj[YxtfWyjcjDjZYxkcXWvIHzleoVtKGmwIF3ER2sh[2WubIOgZZN{\XO|ZXSgZZMhdmW2IIDlZYshfmGudXWgZZQhOTBidV2gZpkhTnW{YT2yJIlvKGOjbHPpeY0h\nKnZTDt[YRqfW1uIFHjeIl3cXS7PUCuNVMz|ryPLh?= NIrnfVM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{G2N|QzPSd-MkOxOlM1OjV:L3G+
1321N1 MYDGeY5kfGmxbjDhd5NigQ>? NWXzdVluOzBibXnudy=> NX3ETZZ4SWexbnnzeEBi[3Srdnn0fUBifCCJRmCgeIFo\2WmLXj1cYFvKFB{WUGgdoVk\XC2b4Kg[ZhxemW|c3XkJIlvKGi3bXHuJFE{OjGQMTDj[YxteyCjc4Pld5Nm\CCjczDlcIV3[XSrb36gbY4h[2GuY3n1cUBt\X[nbDDh[pRmeiB|MDDtbY5{KGK7IH\seY9z\XOlZX7j[UB{eGWldILvdIhwfG:vZYTybYMh[W6jbInzbZMtKEWFNUC9NE4yPc7:TT6= Ml\qQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFyOUC2PFEoRjJzMEmwOlgyRC:jPh?=
NG108-15 NXKxWpRrTnWwY4Tpc44h[XO|YYm= MmTWRYdwdmm|dDDhZ5Rqfmm2eTDheEBROll{IILlZ4VxfG:{IHnuJG5IOTB6LUG1JINmdGy|IDj1cotvd3ewIH;ybYdqdiluIFXDOVA:OC5zON88UU4> MlTaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl{NUS4PVUoRjJ7MkW0PFk2RC:jPh?=
1321N1 Mlj4SpVv[3Srb36gZZN{[Xl? NFPlXIxC\2:waYP0JIFkfGm4aYT5JIF1KE5vdHXycYlv[WxiSFGg[ZBqfG:yZT30ZYdo\WRiaIXtZY4hWDK\MjDy[YNmeHSxcjDSNVc4SSCvdYThcpQh\XiycnXzd4VlKGmwIHj1cYFvKDF|MkHONUBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCrboTyZYNmdGy3bHHyJINidGOrdX2gcIV3\WxuIFXDOVA:OC5zOEROwG0v M2fkTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NEG5NlA1Lz5zOUSxPVIxPDxxYU6=
HEK293 NVPifWhRTnWwY4Tpc44h[XO|YYm= MUHB[49vcXO2IHHjeIl3cXS7IHH0JHAzYTFicnXj[ZB1d3JiZYjwdoV{e2WmIHnuJIh2dWGwIFjFT|I6OyClZXzsd{whTUN3ME2wMlLPxE1w MorTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzN{W1NVcoRjJyMUe1OVE4RC:jPh?=
HEK293 MXrGeY5kfGmxbjDhd5NigQ>? M1O0VGFod26rc4SgZYN1cX[rdImgZZQhemG2IGCyXVFTKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[XO|ZYPz[YQh[XNicnXs[YF{\SCxZjDpcpRz[WOnbHz1cIFzKGOjbHPpeY0h[nliZnz1c5Jme2OnbnPlJIJie2WmIHHzd4F6NCCHQ{WwQVAvOs7:TT6= NGrCfHA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mki3N|Y5QCd-MkK4O|M3QDh:L3G+
CF/T43 MUPGeY5kfGmxbjDhd5NigQ>? NEXsdldC\2:waYP0JIFkfGm4aYT5JIF1KFB{WUKgdoVk\XC2b4KgbY4hcHWvYX6gR2YwXDR|IHPlcIx{NCCHQ{WwQVAvOs7:TT6= NFPnT4M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUK1OFg6PSd-MkmyOVQ5QTV:L3G+
BEA NEnUd4RHfW6ldHnvckBie3OjeR?= NWLFUI9qSWexbnnzeEBi[3Srdnn0fUBifCCSMmmyJJJm[2WydH;yJIlvKEKHQTDj[YxteyBqdX7rco94diCxcnnnbY4qNCCHQ{WwQVAvOs7:TT6= NGr6UpY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUK1OFg6PSd-MkmyOVQ5QTV:L3G+
1321N1 M4\1N2Z2dmO2aX;uJIF{e2G7 NED4RnBC\2:waYP0JIFkfGm4aYT5JIF1KE5vdHXycYlv[WxiSFGg[ZBqfG:yZT30ZYdo\WRiaIXtZY4hWDK\MjDy[YNmeHSxcjDSNVgxSSCvdYThcpQh\XiycnXzd4VlKGmwIHj1cYFvKDF|MkHONUBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCrboTyZYNmdGy3bHHyJINidGOrdX2gcIV3\WxuIFXDOVA:OC5{M{hOwG0v NIfUcXI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUSxPVIxPCd-MUm0NVkzODR:L3G+
1321N1 MofUSpVv[3Srb36gZZN{[Xl? NHnK[4RC\2:waYP0JIFkfGm4aYT5JIF1KE5vdHXycYlv[WxiSFGg[ZBqfG:yZT30ZYdo\WRiaIXtZY4hWDK\MjDy[YNmeHSxcjDSNVc4SV:UMUiwRUBld3WkbHWgcZV1[W62IHX4dJJme3OnZDDpckBpfW2jbjCxN|IyVjFiY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gbY51emGlZXzseYxieiClYXzjbZVuKGyndnXsMEBGSzVyPUCuNlM6|ryPLh?= NVLUUlRPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm0NVkzODRpPkG5OFE6OjB2PD;hQi=>
1321N1 NHfsT2pHfW6ldHnvckBie3OjeR?= MWLB[49vcXO2IHHjeIl3cXS7IHH0JG4ufGW{bXnuZYwhUEFiZYDpeI9x\S22YXfn[YQhcHWvYX6gVFJ[OiC{ZXPldJRweiC\MUG4RUBufXSjboSg[ZhxemW|c3XkJIlvKGi3bXHuJFE{OjGQMTDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBqdnS{YXPlcIx2dGG{IHPhcINqfW1ibHX2[YwtKEWFNUC9NE4zQToQvF2u MkPaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl2MUmyNFQoRjF7NEG5NlA1RC:jPh?=
HEK 293 NX;0SZhbTnWwY4Tpc44h[XO|YYm= MUPDc45k\W62cnH0bY9vKHKncYXpdoVlKG[xcjDjZYxkcXWvIH3vZoltcXqjdHnvckBifCC{YYSgdJVzcW6ncnfpZ{AzYTFicnXj[ZB1d3JiZYjwdoV{e2WmIHnuJGhGUyB{OUOgZ4VtdHNuIFXDOVA:OC53Od88UU4> MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTNzN{S1N{c,OTV|MUe0OVM9N2F-
1321N1 Mnf0SpVv[3Srb36gZZN{[Xl? NVTt[ItDSW62YXfvcol{fGmlIHHjeIl3cXS7IHH0JIh2dWGwIILlZ49u[mmwYX70JHAzYTRicnXj[ZB1d3JiZYjwdoV{e2WmIHnuJFE{OjGQMTDj[YxteyxiS3K9NE44ODkQvF2u NGfZUZE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{OwNlM6QCd-MUezNFI{QTh:L3G+
1321N1 NUfLV|Q2TnWwY4Tpc44h[XO|YYm= NWna[FFtSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBITlBvdHHn[4VlKFB{WUHSJJRz[W6|ZnXjeIVlKGmwIHj1cYFvKDF|MkHONUBk\WyuczDhd5Nme3OnZDDhd{BqdmS3Y4Tpc44hd2ZiaX70doFk\WyudXzhdkBk[WylaYXtJI1w[mmuaYrheIlwdiCkeTDmcJVwemW|Y3XuZ4Uh[XO|YYmsJGVEPTB;MD64Oe69VS5? MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzd3MUC5PEc,OjN5NUGwPVg9N2F-
1321N1 MmOxSpVv[3Srb36gZZN{[Xl? M4PGb|MxKG2rboO= Mn:yRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQNnkyKHKnY3XweI9zKGW6cILld5Nm\CCrbjDoeY1idiBzM{KxUlEh[2WubIOgZZN{\XO|ZXSgZZMhcW6lcnXhd4Uhd2ZiaX70doFk\WyudXzhdkBk[WylaYXtJIxmfmWuIHHmeIVzKDNyIH3pcpMhfXOrbneg[pVz[S1{IFHNJIJ6KG[udX;y[ZNk\W6lZTDhd5NigSxiRVO1NF0xNjh3zszNMi=> MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh2Nke4NUc,OjR6NE[3PFE9N2F-
1321N1 NVXp[mtQTnWwY4Tpc44h[XO|YYm= Moj6RYdwdmm|dDDhZ5Rqfmm2eTDheEBITlBvdHHn[4VlKGi3bXHuJHAzYTGUIITyZY5{\mWldHXkJIlvKGi3bXHuJFE{OjGQMTDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBqdnS{YXPlcIx2dGG{IFPhNkshdGW4ZXygZpkh\nW{YTCyM2FOKHC{b3LlMYJie2WmIH\seY9z\XOlZX7j[UBie3OjeTygSWM2OD1yLki1{txONg>? NWKzb4hrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[0OFc6PDBpPkK2OFQ4QTRyPD;hQi=>
1321N1 NILwPHlHfW6ldHnvckBie3OjeR?= MXTB[49vcXO2IHHjeIl3cXS7IHH0JG4ufGW{bXnuZYwhUEFiZYDpeI9x\S22YXfn[YQhcHWvYX6gVFJ[OiC{ZXPldJRweiCFMke4V{BufXSjboSg[ZhxemW|c3XkJIlvKGi3bXHuJFE{OjGQMTDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBqdnS{YXPlcIx2dGG{IHPhcINqfW1ibHX2[YwtKEWFNUC9Ne69VS5? MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTRzOUKwOEc,OTl2MUmyNFQ9N2F-
1321N1 MlPrSpVv[3Srb36gZZN{[Xl? NW\zU3NIOzBibXnudy=> MmCxRY51[WexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBROlh2IILlZ4VxfG:{IHX4dJJme3OnZDDpckAyOzJzTkGgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCDVGCtbY5lfWOnZDDjfZRwe2:uaXOgZ4Ft[2m3bTDpcoZtfXhiY3;tdI92dmRicILlbY5kfWKjdHXkJIZweiB|MDDtbY5{KGKnZn;y[UBCXFBidILlZZRu\W62IHL5JGZtfW9vNDDBUUBndHWxcnXzZ4Vv[2VibXX0bI9lNCCHQ{WwQVHPxE1w M{TVT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEe1NFY4Lz5{M{C3OVA3PzxxYU6=
Sf9 NVL4VHU6TnWwY4Tpc44h[XO|YYm= NFuyWIxDcW6maX7nJIFn\mmwaYT5JJRwKHerbHSgeJlx\SB4WFjpd{11[WepZXSgbJVu[W5iSlHLNkBLUDJiZH;tZYlvKCh3MUOgeI8hQDJ5IILld4llfWW|KTDlfJBz\XO|ZXSgbY4h[mGldXzveolzfXNiaX7m[YN1\WRiU3[5JINmdGy|IHL5JG1CVlRvQWTQJIJqdmSrbnegZZN{[XluIFvkQVEvO87:TT6= NHzrd|M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MkOyPVYyPyd-M{KzNlk3OTd:L3G+
Sf9 M{f6bWZ2dmO2aX;uJIF{e2G7 NYXJTmdpSmmwZHnu[{Bi\m[rbnn0fUB1dyB4WFjpd{11[WepZXSgbJVu[W5iSlHLNkBLUDJiZH;tZYlvKFZ4MUfGJI12fGGwdDCoOVE{KHSxIEiyO{Bz\XOrZIXld{kh\XiycnXzd4VlKGmwIHLhZ5Vtd3[rcoXzJIlv\mWldHXkJHNnQSClZXzsd{BjgSCPQV7UMWFVWCCkaX7kbY5oKGG|c3H5MEBM\D1zLkROwG0v MlHxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzJ|Mkm2NVcoRjN{M{K5OlE4RC:jPh?=
1321N1 MVnGeY5kfGmxbjDhd5NigQ>? NXnxOFE2SWOldX31cIF1cW:wIH;mJIlvd3OrdH;sJJBpd3OyaHH0[UBqdiBzM{KxUlEh[XO2cn;jfZRwdWFiY3XscJMh\XiycnXzd4lv\yCqdX3hckBROllzIID1dolvd2OncITvdkwhTUN3ME2xMlXPxE1w NX\xU3g6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUG5PFU1PzZpPkGxPVg2PDd4PD;hQi=>
Sf9 M{PrNGZ2dmO2aX;uJIF{e2G7 NF;Lc45DcW6maX7nJIFn\mmwaYT5JJRwKHKnY3;tZolv[W62IHj1cYFvKGKrb4Tpcplt[XSnZDDOMZRmem2rbnHsJGdUXC22YXfn[YQh[XW2b4Doc5NxcG:{eXzheIVlKFSDS{GgLFEhfG9iM{CzJJJme2mmdXXzLUBnfXOnZDD3bZRpKFSDQkGgLFQ{PyC2bzC1NFQhemW|aXT1[ZMqKGW6cILld5Nm\CCrbjDiZYN2dG:4aYL1d{Bqdm[nY4Tl[EB{\jliY3XscJMh[nliU2DSJIF{e2G7LDDL[F0zNjkQvF2u NGDMRXo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEGwPVc6OSd-MkixNFk4QTF:L3G+
1321N1 NVnSfno2TnWwY4Tpc44h[XO|YYm= M163dlMxKG2rboO= M{jYSmFod26rc4SgZYN1cX[rdImgZZQhT0[SIITh[4dm\C2qdX3hckBROllzMTDy[YNmeHSxcjDlfJBz\XO|ZXSgbY4hcHWvYX6gNVMzOU5zIHPlcIx{KGG|c3Xzd4VlKGG|IHXs[ZZifGmxbjDpckBk[WylaYXtJIxmfmWuIHHmeIVzKDNyIH3pcpMh[nliZnz1c5Jme2OnbnPlJJNx\WO2cn;wbI91d22ndILpZ{BidmGueYPpd{whTUN3ME2zMlPPxE1w NHLyPZY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUC5NFY5OSd-MkGwPVA3QDF:L3G+
1321N1 MlTCSpVv[3Srb36gZZN{[Xl? NVjiWo9uSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBITlBvdHHn[4VlKFB{WUGxVkB1emGwc3\lZ5Rm\CCrbjDoeY1idiBzM{KxUlEh[2WubIOgZZN{\XO|ZXSgZZMhcW6mdXP0bY9vKG:oIHnueJJi[2WubIXsZZIh[2GuY3n1cUBud2KrbHn6ZZRqd25iYomg[ox2d3Knc3PlcoNmKGG|c3H5MEBGSzVyPU[uO:69VS5? MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzd3MUC5PEc,OjN5NUGwPVg9N2F-
1321N1 NI\tS2VHfW6ldHnvckBie3OjeR?= MVHB[49vcXO2IHHjeIl3cXS7IHH0JGdHWC22YXfn[YQhcHWvYX6gVFJ[OTGUIITyZY5{\mWldHXkJIlvKGi3bXHuJFE{OjGQMTDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBqdnS{YXPlcIx2dGG{IFPhNkshdGW4ZXygZpkh\nW{YTCyM2FOKHC{b3LlMYJie2WmIH\seY9z\XOlZX7j[UBie3OjeTygSWM2OD14LkhOwG0v M1LTdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4NES3PVQxLz5{NkS0O|k1ODxxYU6=
1321N1 NFnuNllHfW6ldHnvckBie3OjeR?= Ml\IRYdwdmm|dDDhZ5Rqfmm2eTDheEBPNXSncn3pcoFtKEiDIHXwbZRweGVvdHHn[4VlKGi3bXHuJHAzYTJicnXj[ZB1d3JiUkK3NmEhdXW2YX70JIV5eHKnc4Pl[EBqdiCqdX3hckAyOzJzTkGgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hcW62cnHj[YxtfWyjcjDjZYxkcXWvIHzleoVtNCCHQ{WwQVEyNjgQvF2u NITmNXA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUSxPVIxPCd-MUm0NVkzODR:L3G+
1321N1 NH\4dmpHfW6ldHnvckBie3OjeR?= MnLVRYdwdmm|dDDhZ5Rqfmm2eTDifUBu\WG|dYLpcochcW6xc3n0c4wheGixc4DoZZRmKGGlY4XteYxifGmxbjDpckAyOzJzTkGgbJVu[W5iYYP0do9kgXSxbXGgZ4VtdHNic4ThZox6KGW6cILld5NqdmdiaIXtZY4hWDK\IID1dolvd2OncITvdkAyOSxiRVO1NF0yPy5|zszNMi=> NFq4V5U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMUm4OVQ4Pid-MUG5PFU1PzZ:L3G+
1321N1 MWXGeY5kfGmxbjDhd5NigQ>? NUPzPXpJSW62YXfvcol{fGmlIHHjeIl3cXS7IHH0JIh2dWGwIILlZ49u[mmwYX70JHAzYTRicnXj[ZB1d3JiZYjwdoV{e2WmIHnuJFE{OjGQMTDj[Yxtew>? NV7PN41SRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUezNFI{QThpPkG3N|AzOzl6PD;hQi=>
MDCK NVOyTZFbTnWwY4Tpc44h[XO|YYm= NFOyZ5MyOCC3TR?= NEnIemlKdmS3Y4Tpc44hd2ZiaX70doFk\WyudXzhdkBk[WylaYXtJIxmfmWuIHnuJG1FS0tiY3XscJMh[XRiMUCgeW0h[nliRoXyZU0zKGmwIHPhcINqfW1iZoLl[UBu\WSrdX2gbY4heHKnc3XuZ4Uhd2ZiMUCgeW0hXTd|M{SzJIlv[WO2aY\lJIFv[WyxZ4XlJI9nKFV5M{GyNkBxcG:|cHjvcIlx[XOnIFOgbY5pcWKrdH;y NV;lWIRMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOxOlM1OjVpPkKzNVY{PDJ3PD;hQi=>
THLP1 MnzSSpVv[3Srb36gZZN{[Xl? M3yxR2Fod26rc4SgZYN1cX[rdImgZZQhVkyUUEOgbY4hcHWvYX6gWGhNWDFvboXscEBk\WyuczDhd5Nme3OnZDDhd{BqdmS3Y4Tpc44hd2ZiTGDTMYlv\HWlZXSgTWwuOWKndHGgd4VkemW2aX;uJIJ6KEiHSz3CcJVmKHKncH;yeIVzKGOnbHygZoF{\WRiYYPzZZk> NFq3[489[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEiyPVU6QSd-Mki4Nlk2QTl:L3G+
HEK293 NHXme2ZHfW6ldHnvckBie3OjeR?= M3nwc|EhfU1? NXyzR|Q3SWexbnnzeEBi[3Srdnn0fUBifCCDTGivSnBTOiBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[29vZYjwdoV{e2mwZzDHZYxxcGGzIHHzd4V{e2WmIHHzJIlv\HWldHnvckBw\iCrboTyZYNmdGy3bHHyJINidGOrdX2gZYNkfW23bHH0bY9vKGG2IEGgeW0h[nliRnz1c{01KGS7ZTDiZZNm\CCobIXvdoV{[2WwY3Wgd5Bm[3S{b4Doc5RwdWW2cnnjJIF{e2G7 MoPYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzB2MUm0PVMoRjNyNEG5OFk{RC:jPh?=
HEK293 MorJSpVv[3Srb36gZZN{[Xl? MWexJJVO NGq5S2lKdmS3Y4Tpc44hd2ZiaX70doFk\WyudXzhdkBk[WylaYXtJIFk[3WvdXzheIlwdiCrbjDISWszQTNiY3XscJMh[XRiMTD1UUBjgSCIbIXvMVQh\HmnIHLhd4VlKG[udX;y[ZNk\W6lZTDzdIVkfHKxcHjveI9u\XS{aXOgZZN{[Xl? M4HucVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyNEG5OFk{Lz5|MESxPVQ6OzxxYU6=
BL21(DE3) NIXLc2FHfW6ldHnvckBie3OjeR?= NGXGcFdC[3Srdnn0fUBw\iCEYXPpcIx2eyC|dXL0bYxqeyCQLYTldo1qdmGuIFjpd{11[WepZXSgRW5VMDZrIHX4dJJme3OnZDDpckBGe2OqZYLpZ4hq[SClb3zpJGJNOjFqRFWzLUBk\WyuczDhd5Nme3OnZDDhd{Bi\GWweXzheIVlKHC{b3T1Z5Qh[nliTXnjbIFmdGm|LV3lcpRmdiCtaX7leIlkew>? NHTFWXU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDJ2OT:nQmNpTU2ETEyvZV4>
In vivo

ATP regulates microglial branch dynamics in the intact mice brain, and its release from the damaged tissue and surrounding astrocytes mediates a rapid microglial response towards injury. [5]

Protocol (from reference)

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 551.14
Formula

C10H14N5O13P3.2Na

CAS No. 987-65-5
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)([O-])OP(=O)(O)[O-])O)O)N.[Na+].[Na+]

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT05426785 Not yet recruiting Device: 1:1 ratio for Treatment Group and Control Group Implantable Cardioverter Defibrillator(ICD) Biotronik SE & Co. KG|Biotronik Japan Inc. September 30 2022 Not Applicable
NCT05419596 Not yet recruiting Procedure: Urologic Surgery Cognitive Dysfunction Istanbul University July 1 2022 --
NCT05410873 Not yet recruiting Drug: MitoQ Compound|Drug: Placebo Dilated Cardiomyopathy Imperial College London|British Heart Foundation July 18 2022 Phase 2

(data from https://clinicaltrials.gov, updated on 2022-08-01)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy ATP disodium | ATP disodium ic50 | ATP disodium price | ATP disodium cost | ATP disodium solubility dmso | ATP disodium purchase | ATP disodium manufacturer | ATP disodium research buy | ATP disodium order | ATP disodium mouse | ATP disodium chemical structure | ATP disodium mw | ATP disodium molecular weight | ATP disodium datasheet | ATP disodium supplier | ATP disodium in vitro | ATP disodium cell line | ATP disodium concentration | ATP disodium nmr